Crowdonomics
All companies

AIBOTICS, INC.

Public

Biotech · Heyburn, ID

Estimated pre-money ⓘ
$2.1M
As of Apr 2025 · from Reg A Offering (2025) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$1,620,000
Crowd $0 · Private $1.6M · 5 rounds since 2021
Latest share price
$0.05
Reg A Offering (2025) offering price

Financials

FY2018–FY2025 · from SEC filings · hover any figure for its source
$0
$61K
2018
$0
$5K
2019
$0
−$242K
2020
−$2.8M
2021
−$2.8M
2022
−$1.2M
2023
$0
−$1.8M
2024
$2K
−$2.2M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018 audited
FY2019 audited
FY2020 audited
FY2021 audited
FY2022 audited
FY2023 audited
FY2024 audited
FY2025 audited
Income statement
Revenue
$0
$0
$0
—
—
—
$0
$2,183
Cost of goods sold
$0
$0
$2,354,600
—
—
—
$531,647
—
Net income
$61,202
$4,803
-$242,205
-$2,820,730
-$2,751,452
-$1,181,347
-$1,848,275
-$2,215,751
Taxes paid
$0
$0
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$611,497
$709,164
$57,359
$1,267,519
$385,899
$279,134
$185,097
$255,940
Accounts receivable
$0
$1,000
$0
—
—
—
$0
—
Total assets
$1,499,975
$1,215,133
$455,455
$1,270,016
$387,395
$2,219,413
$1,456,995
$874,673
Long-term debt
—
—
$500,000
—
—
—
$0
—
Total liabilities
$852,875
$563,230
$1,149
$929,995
$1,278,743
$4,247,723
$4,851,763
$4,834,905
Other
Headcount
—
—
1
—
—
—
1
—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$139.6M
est. pre-money
$2.1M
est. pre-money
Reg A+ · Equity · Jan 2022
Reg A+ · Equity · Apr 2025

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Apr 15, 2026
Series B Preferred Stock · 0.04%Common Stock · 100.0%
ClassOutstandingVotes / shareShare of totalLast price
Series B Preferred Stockpreferred(as of Dec 31, 2025)200,000—0.04%—
Common Stock567,695,4921100.0%—
Total567,895,492100%

Shares outstanding over timein today's share terms

568M284M0
Dec 2019Apr 2026
Common StockRound openedSplit / conversion

Changes in named holdersshares in today's terms · % of all shares at the time

Principal holders% as the filing states it, Apr 15, 2026

  • Ben Kaplan95,250,000 Common Stock19.6%of company
  • Ehave Inc.9,793,754 Common Stock2%of company
  • Mark Croskery10,016,912 Common Stock2%of company
  • Mark D. Williams999,997 Common Stock0.2%of company
  • Everyone else (not named in filings)76.2%

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $0 / $5MEst. pre-money $2.1M
Raised $0 / $15MEst. pre-money $139.6M

Team

2 people
Ben Kaplan (1)
President, Chief Executive and Financial Officer, Director
Mark Croskery (1)
Director

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

  • Form 10-QAug 19, 20260001096906-26-001264
    EDGAR
  • Form 10-QJun 9, 20260001096906-26-000922
    EDGAR
  • Form 10-KApr 15, 20260001096906-26-000555
    EDGAR
  • Form 10-QNov 19, 20250001096906-25-001895
    EDGAR
  • Form 10-QAug 19, 20250001096906-25-001375
    EDGAR
  • Form 253G2Jul 3, 20250001096906-25-001087
    EDGAR
  • Form QUALIFJul 1, 20259999999994-25-000124
    EDGAR
  • Form 1-A/AJun 27, 20250001096906-25-001058
    EDGAR
Source: SEC EDGARCIK 0001763329NVShare price $0.05Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.